PANTHERx Rare, founded in 2011 and headquartered in Pittsburgh, PA, is the largest independent rare disease pharmacy in the United States. The company serves exclusively people living with rare and orphan health conditions, their families, and care teams. It is licensed in all 50 states.
Central to the company's operations is the SWFT™ technology platform, which powers its RxARECARE® model - a care approach designed to make rare disease treatment more personalised and manageable for patients. The firm's work sits at the intersection of healthcare, pharmacy, and technology, with a focus on pharmacy technology platforms.
PANTHERx Rare holds dual accreditations in rare disease from ACHC and URAC, the first national pharmacy to achieve this distinction. It has also received nine MMIT Patient Choice Awards for patient satisfaction, including the 2026 honour.
